KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $11.4 billion.

  • Cvs Health's Non-Current Deferred Tax Liability fell 48.19% to $11.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.4 billion, marking a year-over-year decrease of 48.19%. This contributed to the annual value of $11.4 billion for FY2025, which is 48.19% down from last year.
  • Cvs Health's Non-Current Deferred Tax Liability amounted to $11.4 billion in Q4 2025, which was down 48.19% from $3.5 billion recorded in Q3 2025.
  • Cvs Health's Non-Current Deferred Tax Liability's 5-year high stood at $13.8 billion during Q4 2021, with a 5-year trough of $3.5 billion in Q3 2022.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $5.0 billion (2022), whereas its average is $6.5 billion.
  • As far as peak fluctuations go, Cvs Health's Non-Current Deferred Tax Liability plummeted by 4457.26% in 2022, and later skyrocketed by 2115.17% in 2023.
  • Over the past 5 years, Cvs Health's Non-Current Deferred Tax Liability (Quarter) stood at $13.8 billion in 2021, then decreased by 13.78% to $11.9 billion in 2022, then increased by 3.73% to $12.3 billion in 2023, then dropped by 7.31% to $11.4 billion in 2024, then fell by 0.48% to $11.4 billion in 2025.
  • Its last three reported values are $11.4 billion in Q4 2025, $3.5 billion for Q3 2025, and $3.6 billion during Q2 2025.